Honeywell Recalls Eyewash Solution
The company is making the recall in cooperation with FDA and indicated no injuries have been reported and it has not found any contamination in its batch testing, adding, "the voluntary recall is a precautionary measure due to a low risk of product contamination with Klebsiella pneumoniae.
The U.S. Food and Drug Administration announced Aug. 19 that Honeywell is voluntarily recalling one production lot of 32-ounce bottles of Eyesaline Eyewash solution. The company is making the recall in cooperation with FDA and indicated no injuries have been reported and it has not found any contamination in its batch testing, adding, "the voluntary recall is a precautionary measure due to a low risk of product contamination with Klebsiella pneumoniae. Although found in the normal flora of the mouth and skin, if the contaminant were present in a bottle, there is a potential for it to result in infections that may be sight-threatening."
The product is sold through industrial sales distributors, and approximately 9,700 of the bottles with lot number F16091-61 are subject to the recall. No other lot number of this product is subject to the recall.
Honeywell distributors who received this lot have been notified by phone, e-mail, and certified mail and have been instructed to notify their customers.
Distributors must stop distribution of the affected product and return it to Honeywell for credit or replacement; commercial/industrial users of the product should also check whether their Eyesaline Eyewash is subject to recall. If it is, customers should stop using the solution and contact their distributor for replacement or credit.
The affected product and lot number can be identified as follows:
- Product: 32-ounce Eyesaline Eyewash
- Lot number: F16091-61
- The lot number can be found on the outside of the product case and on individual bottles.
Customers with questions about the recall can contact their distributor or Honeywell Customer Care at 800-430-5490 weekdays, 8 a.m. to 6:30 p.m. EST. The company said customers should contact their physician or health care provider if they have experienced any problem that may be related to taking or using the product.